Stay updated on CDX-0159 in Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 in Eosinophilic Esophagitis Clinical Trial page.

Latest updates to the CDX-0159 in Eosinophilic Esophagitis Clinical Trial page
- Check2 days agoChange DetectedThe page shows a new revision label (v3.6.4) replacing the previous v3.6.3, indicating a minor update to the page build. The change does not affect what users see or how the page operates.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3, signaling a newer build of the page. This change represents an internal release update without altering study details or visible content.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now shows 'No longer looking for participants', signaling that the study is not enrolling any more participants. Additionally, navigation/help items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the 'Intervention/Treatment' labeling was adjusted along with a site revision note.SummaryDifference0.3%

- Check45 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 to reflect a newer page version. This appears to be a minor software/template update rather than a content change.SummaryDifference0.0%

- Check52 days agoChange DetectedThe study record now lists the intervention as CDX-0159 (barzolvolimab) administered subcutaneously as a Biological. Related entries such as 'Other Names' and administration details have been updated (dated 2026-05-27 and 2026-05-22).SummaryDifference0.5%

- Check67 days agoChange DetectedPage revision label updated from v3.5.3 to v3.5.4. This indicates a minor update to the page's documentation.SummaryDifference0.0%

Stay in the know with updates to CDX-0159 in Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 in Eosinophilic Esophagitis Clinical Trial page.